Home » Health » Health Information » Human Health » Life Sciences » Medical Daily » Medicine » Natural Health News » Science and Health » Science and Research » Weight Loss Drug Belviq May Increase Cancer Risk, FDA Reports Weight Loss Drug Belviq May Increase Cancer Risk, FDA Reports January 16, 2020 Medical Daily Off Health, Health Information, Human Health, Life Sciences, Medical Daily, Medicine, Natural Health News, Science and Health, Science and Research FDA warns the obesity-fighting drug, Belviq, might be associated with an increased risk of cancer. Read Original Article: Weight Loss Drug Belviq May Increase Cancer Risk, FDA Reports » Share...FacebookPinterestTwitterLinkedinRedditTumblr Previous: Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline Next: Should You Get A Flu Shot Every Year? About The Author Medical Daily